3-135166038-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004441.5(EPHB1):āc.1656C>Gā(p.Phe552Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004441.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPHB1 | NM_004441.5 | c.1656C>G | p.Phe552Leu | missense_variant | 8/16 | ENST00000398015.8 | NP_004432.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPHB1 | ENST00000398015.8 | c.1656C>G | p.Phe552Leu | missense_variant | 8/16 | 1 | NM_004441.5 | ENSP00000381097 | P1 | |
ENST00000649588.1 | n.329-7710G>C | intron_variant, non_coding_transcript_variant | ||||||||
EPHB1 | ENST00000647596.1 | c.1656C>G | p.Phe552Leu | missense_variant | 8/16 | ENSP00000497153 | ||||
EPHB1 | ENST00000493838.1 | c.339C>G | p.Phe113Leu | missense_variant | 6/14 | 2 | ENSP00000419574 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461664Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727116
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.1656C>G (p.F552L) alteration is located in exon 8 (coding exon 8) of the EPHB1 gene. This alteration results from a C to G substitution at nucleotide position 1656, causing the phenylalanine (F) at amino acid position 552 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at